Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — Data - Healthy People 2030

Status: Baseline only

Learn more about our data release schedule

Most Recent Data:
43.0 percent (2013-16) *

Target:
55.4 percent *

Desired Direction:
Increase desired

Baseline:
43.0 percent of adults aged 18 years and over with diagnosed diabetes and chronic kidney disease received recommended medical treatment with ACE inhibitors or ARBs in 2013-16 *

* Age adjusted to the year 2000 standard population.

Download CKD-05 data [CSV]

Data Chart
Data Table

Show disparities data *

Show confidence interval (CI)

Show standard error (SE)

Confidence Interval (CI) not available Standard Error (SE) not available

Show disparities data *

**Adults with diagnosed diabetes and chronic kidney disease receiving recommended treatment** ^* ^◊
(percent), **2013-16**
Population	2013-16
Total	43.0

Data Source: National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

#: Standard errors and confidence intervals are not available for this population group.

*: Age adjusted to the year 2000 standard population.

◊: Unless otherwise noted, data represent "percent, 18+ years"

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.

Learn more about data measurement for this objective

Increase the proportion of adults with diabetes and chronic kidney disease who get ACE inhibitors or ARBs — CKD‑05 Data

Status: Baseline only